Home › Companies › The Oncology Institute, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and The Oncology Institute, Inc.’s Form 8-K, filed June 18, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 17, 2026: 10 items on The Oncology Institute, Inc.’s Form 8-K, filed June 18, 2026: 2 approved · 8 passed (calculated).
Notable dissent: 1 director (10.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2025-2026
Explore The Oncology Institute, Inc. in the interactive database Compare manager voting policies
These tallies are The Oncology Institute, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Brad Hively | 24,098,631 | -- | -- | 1,477,084 | 49,666,722 | 94% | Passed (calculated) | — |
| Elect Director: Karen Johnson | 23,014,174 | -- | -- | 2,561,541 | 49,666,722 | 90% | Passed (calculated) | — |
| Elect Director: Mohit Kaushal | 24,061,396 | -- | -- | 1,514,319 | 49,666,722 | 94% | Passed (calculated) | — |
| Elect Director: Anne McGeorge | 24,062,503 | -- | -- | 1,513,212 | 49,666,722 | 94% | Passed (calculated) | — |
| Elect Director: Mark Pacala | 24,068,647 | -- | -- | 1,507,068 | 49,666,722 | 94% | Passed (calculated) | — |
| Elect Director: Mark Stolper | 24,102,389 | -- | -- | 1,473,326 | 49,666,722 | 94% | Passed (calculated) | — |
| Elect Director: Kimberly Tzoumakas | 24,102,880 | -- | -- | 1,472,835 | 49,666,722 | 94% | Passed (calculated) | — |
| Elect Director: Daniel Virnich | 25,528,398 | -- | -- | 47,317 | 49,666,722 | 99.8% | Passed (calculated) | — |
| 2. Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, P.C | 75,098,890 | 37,257 | 106,290 | -- | -- | 99.9% | Approved | — |
| 3. Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal | 25,280,934 | 282,655 | 12,126 | -- | 49,666,722 | 99% | Approved | — |
Source: The Oncology Institute, Inc., Form 8-K, filed with the SEC on June 18, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
109 asset managers disclosed a vote on at least one The Oncology Institute, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of The Oncology Institute, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 98.5% for (May 7, 2025 meeting) ▼ 4.4 pts
Description as filed by funds: Election of eight directors: Anne McGeorge
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Anne McGeorge”): 24,062,503 for, 1,513,212 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,180,409 | 0 | 7 | 8,184 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,916,577 for, 14,634 withheld, 7 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 88.2% for (May 7, 2025 meeting) ▲ 6.0 pts
Description as filed by funds: Election of eight directors: Brad Hively
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Brad Hively”): 24,098,631 for, 1,477,084 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,183,099 | 0 | 7 | 5,495 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,925,293 for, 5,919 withheld, 7 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Combines 3 wordings of this item as funds reported it.
99.8% Majority: yes · of votes cast
Prior year: 99.8% for (May 7, 2025 meeting) unchanged
Description as filed by funds: Election of eight directors: Daniel Virnich
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Daniel Virnich”): 25,528,398 for, 47,317 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 99.8% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,188,601 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,931,219 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Combines 3 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 86.5% for (May 7, 2025 meeting) ▲ 3.5 pts
Description as filed by funds: Election of eight directors: Karen Johnson
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Karen Johnson”): 23,014,174 for, 2,561,541 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 90% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,183,094 | 0 | 12 | 5,495 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 0 | 0 | 0 | 39,675 | Withhold |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 0 | 0 | 0 | 31,772 | Withhold |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 0 | 19,818 | Withhold |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 0 | 0 | 12,880 | Withhold |
| ProShares | 0 | 0 | 0 | 11,704 | Withhold |
| Brighthouse | 0 | 0 | 0 | 11,109 | Withhold |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 0 | 0 | 0 | 7,386 | Withhold |
Fund voting reports, all 39 managers: 7,778,944 for, 152,263 withheld, 12 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of eight directors: Kimberly Tzoumakas
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Kimberly Tzoumakas”): 24,102,880 for, 1,472,835 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,188,594 | 0 | 7 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,931,212 for, 7 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 98.5% for (May 7, 2025 meeting) ▼ 4.4 pts
Description as filed by funds: Election of eight directors: Mark Pacala
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mark Pacala”): 24,068,647 for, 1,507,068 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,183,099 | 0 | 7 | 5,495 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,925,293 for, 5,919 withheld, 7 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Description as filed by funds: Election of eight directors: Mark Stolper
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mark Stolper”): 24,102,389 for, 1,473,326 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,185,904 | 0 | 7 | 2,690 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,928,522 for, 2,690 withheld, 7 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Combines 3 wordings of this item as funds reported it.
94% Majority: yes · of votes cast
Prior year: 98.6% for (May 7, 2025 meeting) ▼ 4.6 pts
Description as filed by funds: Election of eight directors: Mohit Kaushal
The Oncology Institute, Inc.’s own tally for this item (“Elect Director: Mohit Kaushal”): 24,061,396 for, 1,514,319 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts using a plurality of the votes cast, the standard stated in the company’s proxy statement: votes for exceeded votes against.
Support: 94% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,183,099 | 0 | 7 | 5,495 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,925,293 for, 5,919 withheld, 7 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Combines 2 wordings of this item as funds reported it.
99% Approved · of votes cast
Description as filed by funds: APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
The Oncology Institute, Inc.’s own tally for this item (“3. Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal”): 25,280,934 for, 282,655 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: Approval, on a non-binding, advisory basis, of the Company's named executive officers (the "Say-on-Pay Proposal") The Say-on-Pay Proposal was approved.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Also reported under other wordings, matched to the same row of The Oncology Institute, Inc.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote to Ratify Named Executive Officers' Compensation” (2 managers, 1,716,011 for).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,188,600 | 1 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,923,654 for, 7,565 against. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3,274,985 | 0 | 0 | 0 | For |
| BlackRock | 802,300 | 30,046 | 0 | 0 | For |
| State Street | 640,541 | 2,319 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 578,844 | 0 | 0 | 0 | For |
| Vanguard | 411,365 | 0 | 0 | 0 | For |
| Northern Trust | 293,830 | 2,467 | 0 | 0 | For |
| Mount Lucas Management LP | 250,000 | 0 | 0 | 0 | For |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 212,072 | 21,517 | 0 | 0 | Mixed |
| Charles Schwab | 214,915 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 150,454 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 0 | 119,359 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 116,254 | 0 | 0 | 0 | For |
| HighTower Advisors, LLC | 85,862 | 0 | 0 | 0 | For |
| Goldman Sachs | 81,713 | 0 | 0 | 0 | For |
| Lee Financial Co | 81,362 | 0 | 0 | 0 | For |
| Capital Group | 70,192 | 0 | 0 | 0 | For |
| AllianceBernstein | 61,600 | 0 | 0 | 0 | For |
| JPMorgan | 58,412 | 0 | 0 | 0 | For |
| AQR | 44,213 | 0 | 0 | 0 | For |
| Invesco | 0 | 32,326 | 0 | 0 | Against |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Holt Capital Advisors, L.L.C. dba Holt Capital Partners, L.P | 29,534 | 0 | 0 | 0 | For |
| Prudential/PGIM | 26,525 | 0 | 0 | 0 | For |
| State of Wyoming | 20,262 | 0 | 0 | 0 | For |
Institutional-manager reports, all 83 managers: 11,266,826 for, 227,682 against, 9,094 1 year. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.9% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE PREFERRED FREQUENCY OF FUTURE ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| World Funds Trust | 0 | 0 | 0 | 0 | -- |
| TIFF INVESTMENT PROGRAM | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| GPS Funds I | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| AIG/SunAmerica | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 39 managers: 11,109 for, 7,919,995 1 year, 115 unknown. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Ensign Peak Advisors, Inc | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Mount Lucas Management LP | 0 | 0 | 0 | 0 | -- |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| HighTower Advisors, LLC | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| Lee Financial Co | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| JPMorgan | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| Holt Capital Advisors, L.L.C. dba Holt Capital Partners, L.P | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| State of Wyoming | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 83 managers: 3,521,902 for, 370 against, 7,401,486 1 year, 579,844 3 year. Showing the 25 largest; every one is in the interactive database (link above).
99.9% Approved · of votes cast
Prior year: 98.9% for (May 7, 2025 meeting) ▲ 1.0 pts
Description as filed by funds: RATIFICATION OF THE APPOINTMENT OF BDO AS THE INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM OF THE COMPANY FOR 2026.
The Oncology Institute, Inc.’s own tally for this item (“2. Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, P.C”): 75,098,890 for, 37,257 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2: Ratification of the Appointment of Independent Registered Public Accountants The ratification of the appointment of BDO USA, P.C. as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 4,188,601 | 0 | 0 | 0 | For |
| BlackRock | 1,378,086 | 0 | 0 | 0 | For |
| World Funds Trust | 1,000,000 | 0 | 0 | 0 | For |
| TIFF INVESTMENT PROGRAM | 352,849 | 0 | 0 | 0 | For |
| Charles Schwab | 214,890 | 0 | 0 | 0 | For |
| Goldman Sachs | 178,726 | 0 | 0 | 0 | For |
| JPMorgan | 98,010 | 0 | 0 | 0 | For |
| Equitable | 82,561 | 0 | 0 | 0 | For |
| Lincoln Financial | 74,538 | 0 | 0 | 0 | For |
| Fidelity | 43,046 | 0 | 0 | 0 | For |
| AQR | 39,675 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 39,638 | 0 | 0 | 0 | For |
| Global X | 34,575 | 0 | 0 | 0 | For |
| Voya | 31,772 | 0 | 0 | 0 | For |
| Pacific Life | 23,901 | 0 | 0 | 0 | For |
| John Hancock | 19,818 | 0 | 0 | 0 | For |
| GPS Funds I | 15,839 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 14,040 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 12,880 | 0 | 0 | 0 | For |
| ProShares | 11,704 | 0 | 0 | 0 | For |
| Brighthouse | 11,109 | 0 | 0 | 0 | For |
| TIAA | 8,810 | 0 | 0 | 0 | For |
| Northern Trust | 8,686 | 0 | 0 | 0 | For |
| SEI | 7,600 | 0 | 0 | 0 | For |
| Victory Capital | 7,386 | 0 | 0 | 0 | For |
Fund voting reports, all 39 managers: 7,931,219 for. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Kanen Wealth Management LLC | 3,513,178 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 3,513,178 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 99,982,933 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.19% |
| 2 | BlackRock | 1.38% |
| 3 | World Funds Trust | 1.00% |
| 4 | TIFF INVESTMENT PROGRAM | 0.35% |
| 5 | Charles Schwab | 0.21% |
| 6 | Goldman Sachs | 0.18% |
| 7 | JPMorgan | 0.10% |
| 8 | Equitable | 0.08% |
| 9 | Lincoln Financial | 0.07% |
| 10 | Fidelity | 0.04% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Kanen Wealth Management LLC | 3.51% |
| 2 | DEERFIELD MANAGEMENT COMPANY, L.P. | 3.28% |
| 3 | BlackRock | 0.83% |
| 4 | State Street | 0.64% |
| 5 | Ensign Peak Advisors, Inc | 0.58% |
| 6 | Vanguard | 0.41% |
| 7 | Northern Trust | 0.30% |
| 8 | Mount Lucas Management LP | 0.25% |
| 9 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 0.23% |
| 10 | Charles Schwab | 0.21% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| Jorey Chernett | 10,499,358 | 10.50% | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
| Chernett Jorey | 10,115,944 | 10.12% | Schedule 13G, filed March 16, 2026 |
| Parian Global TOI LP | 9,382,621 | 9.38% | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
| M33 Growth I L.P. | 5,002,656 | 5.00% | Schedule 13D, filed May 15, 2026 |
| Vanguard Group | 4,748,635 | 4.75% | Form 13F, quarter ended March 31, 2026 |
| BlackRock | 4,415,867 | 4.42% | Form 13F, quarter ended March 31, 2026 |
| Citadel Advisors | 2,354,667 | 2.36% | Form 13F, quarter ended March 31, 2026 |
| Daniel Virnich | 2,211,487 | 2.21% | Proxy statement (DEF 14A), proxy filed April 30, 2026 |
| Geode Capital | 1,757,847 | 1.76% | Form 13F, quarter ended March 31, 2026 |
| State Street | 1,461,454 | 1.46% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 99,982,933 shares outstanding, as reported by The Oncology Institute, Inc. on its Form 10-Q dated April 30, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At The Oncology Institute, Inc.'s shareholder meeting held June 17, 2026, in the 2025-2026 proxy season, 109 asset managers reported votes on at least one item in their SEC Form N-PX filings, covering 1,337 separate fund positions. Their filings are grouped here into 11 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — APPROVAL, ON A NON-BINDING, ADVISORY BASIS, OF THE COMPENSATION OF THE COMPANY'S NAMED… — The Oncology Institute, Inc.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: The Oncology Institute, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from The Oncology Institute, Inc.’s 10-Q dated April 30, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
The Oncology Institute, Inc. proxy season coverage: 2025-2026 (this page).
Proxy Votes Now, “Oncology Institute (STLN) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/the-oncology-institute-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.